Related Experiment Video

Updated: Jun 6, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Obstructive coronary disease in patients with chronic liver disease awaiting liver transplantation

Moacir Fernandes de Godoy1, Patricia de Oliveira Roveri, Marcio Antonio dos Santos

  • 1Faculdade de Medicina de São José do Rio Preto, SP, Brazil. moacirgodoy@cardiol.br

Arquivos Brasileiros De Cardiologia
|December 15, 2010
PubMed

Insights

In advanced liver failure (ALF), hypertension is the only significant risk factor for coronary artery disease (CAD). Managing hypertension may help prevent or delay CAD in ALF patients awaiting liver transplantation.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Advanced liver failure (ALF) often presents with hypocholesterolemia.
  • Some ALF patients develop obstructive coronary artery disease (CAD), increasing liver transplant risks.

Purpose of the Study:

  • To investigate the role of traditional coronary artery disease risk factors in ALF patients.
  • To compare risk factors between ALF patients with and without obstructive CAD.

Main Methods:

  • Coronary angiography was performed on 119 ALF patients over 40.
  • Risk factors for CAD were evaluated in patients undergoing evaluation for liver transplantation.

Main Results:

  • Obstructive CAD was found in 17.6% of ALF patients.
  • Cholesterol levels were low in all patients, with no significant difference between groups.
  • Hypertension was the only statistically significant risk factor for CAD (P=0.0474).

Conclusions:

  • Hypertension is a key risk factor for CAD in ALF patients awaiting liver transplantation.
  • This modifiable risk factor suggests therapeutic interventions to prevent or delay CAD.
Abstract

More Related Videos

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...